CPT-II deficiency needs to be detected in army personnel

被引：0
|
作者：
Finsterer, Josef [1 ]
机构：
[1] Krankenanstalt Rudolfstiftung Wien, Vienna, Austria
来源：
MOLECULAR GENETICS AND METABOLISM REPORTS | 2018年 / 16卷
关键词：
Mitochondrial; SANDO; POLG1; Sudden cardiac death; Takotsubo;
D O I：
10.1016/j.ymgmr.2018.05.005
中图分类号：
Q3 [遗传学];
学科分类号：
071007 ; 090102 ;
摘要：
引用
收藏
页码：11 / 11
页数：1
相关论文
共 50 条
  • [41] CPT-II and concomitant hyperfractionated accelerated radiotherapy induce efficient local control in rectal cancer patients: results from a phase II
    Voelter, V.
    Zouhair, A.
    Vuilleumier, H.
    Matter, M.
    Bouzourene, H.
    Leyvraz, S.
    Bauer, J.
    Coucke, P.
    Stupp, R.
    BRITISH JOURNAL OF CANCER, 2006, 95 (06) : 710 - 716
  • [42] DEVELOPMENT AND CHARACTERIZATION OF A POLYCLONAL ANTIBODY AGAINST RAT-LIVER MITOCHONDRIAL OVERT CARNITINE PALMITOYLTRANSFERASE (CPT-I) - DISTINCTION OF CPT-I FROM CPT-II AND OF ISOFORMS OF CPT-I IN DIFFERENT TISSUES
    KOLODZIEJ, MP
    CRILLY, PJ
    CORSTORPHINE, CG
    ZAMMIT, VA
    BIOCHEMICAL JOURNAL, 1992, 282 : 415 - 421
  • [43] Mutation and biochemical analysis in carnitine palmitoyltransferase type II (CPT II) deficiency
    Olpin, SE
    Afifi, A
    Clark, S
    Manning, NJ
    Bonham, JR
    Dalton, A
    Leonard, JV
    Land, JM
    Andresen, BS
    Morris, AA
    Muntoni, F
    Turnbull, D
    Pourfarzam, M
    Rahman, S
    Pollitt, RJ
    JOURNAL OF INHERITED METABOLIC DISEASE, 2003, 26 (06) : 543 - 557
  • [44] THE MOLECULAR-BASES OF CARNITINE PALMITOYLTRANSFERASE (CPT)-II DEFICIENCY
    TARONI, F
    VERDERIO, E
    CAVADINI, P
    LAMANTEA, E
    GELLERA, C
    DIDONATO, S
    AMERICAN JOURNAL OF HUMAN GENETICS, 1993, 53 (03) : 155 - 155
  • [45] A novel amino acid substitution in a patient with CPT II deficiency
    Kaufmann, P
    OConnell, S
    ElSchahawi, M
    Shanske, S
    DiMauro, S
    NEUROLOGY, 1997, 48 (03) : 5118 - 5118
  • [46] Prevalence of glucose-6-phosphate dehydrogenase deficiency in US Army personnel
    Murray, Clinton K.
    Chinevere, Troy D.
    Grant, Earl, Jr.
    Johnson, Gregory A.
    Duelm, Felix
    Hospenthal, Duane R.
    MILITARY MEDICINE, 2006, 171 (09) : 905 - 907
  • [47] A phase II experience with neoadjuvant irinotecan (CPT-II), 5-fluorouracil (5-FU) and leucovorin (LV) for colorectal liver metastases
    Bathe, Oliver F.
    Ernst, Scott
    Sutherland, Francis R.
    Dixon, Elijah
    Butts, Charles
    Bigam, David
    Holland, David
    Porter, Geoffrey A.
    Koppel, Jennifer
    Dowden, Scot
    BMC CANCER, 2009, 9
  • [48] Selective modulation of carnitine long-chain acyltransferase activities - Kinetics, inhibitors, and active sites of COT and CPT-II
    Ramsay, RR
    Gandour, RD
    CURRENT VIEWS OF FATTY ACID OXIDATION AND KETOGENESIS: FROM ORGANELLES TO POINT MUTATIONS, 1999, 466 : 103 - 109
  • [49] Examining self-reported fatigue and the Variability Index of Connors' Continuous Performance Test-II (CPT-II) in individuals with multiple sclerosis
    Bauer, L.
    Bruce, J. M.
    Westervelt, H. J.
    ARCHIVES OF CLINICAL NEUROPSYCHOLOGY, 2008, 23 (06) : 720 - 720
  • [50] Phase II study of neoadjuvant 5-FU plus leucovorin plus CPT-II in patients with resectable liver metastases from colorectal adenocarcinoma
    Bathe, OF
    Dowden, S
    Sutherland, F
    Dixon, E
    Butts, C
    Bigam, D
    Walley, B
    Ruether, D
    Ernst, S
    BMC CANCER, 2004, 4 (1)
12345